DIA’s 21th Annual EuroMeeting, March 23-25, 2009
Internationales Congress Centrum, Berlin, Germany

Planning to attend the EuroMeeting? If so, take the chance to meet us. Véronique Basch, Head of Drug Safety, and Géraldine Aubes, Project Manager Integrated Safety Services, will be there. Please contact us if you wish to arrange a meeting.

At the very heart of Europe, Berlin is a bridge between east and west and over the last few years has evolved into a major platform for communication and knowledge transfer. And 2009 is a special year to be in Berlin, marking the 20th anniversary of the fall of the Berlin Wall. Europe provides a contrasting perspective to the global drug market that is not fully understood by colleagues around the world.

The EuroMeeting provides a once-a-year opportunity to explain it all. EU healthcare regulation operates at both country and continent levels creating an environment full of complexity and subtlety. However, and some may say despite this, there is a highly successful pharmaceuticals market together with pioneering drug development activities and fair reward. The European Union enlargement has effectively integrated the eastern countries into this market.

At the regulatory level, EMEA has arguably spearheaded the quest for technology solutions with EudraVigilance and EudraCT databases as examples whilst competent authorities can point to their own successful implementations. Accompanying this progress are certain regional complexities that are being addressed such as patient interests and confidentiality of records, freedom of information and evolving drug-device combination products.